in a multicenter , double blind , parallel group study , 233 patients with classical or definite rheumatoid arthritis ( ra ) were randomized to 12 weeks of either salsalate ( salicylsalicylic acid , nonacetylated salicylate ) or aspirin following disease flare .
C0003873
rheumatoid arthritis
C0004057
aspirin